Study to Assess the Safety, Tolerability, PK and PD of ABX1100

NCT06109948 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aro Biotherapeutics